Inventor · disambiguated record
Nathan Elliott Fishkin
Also filed as: FISHKIN NATHAN · FISHKIN NATHAN ELLIOTT
27 granted patents·12 pending applications·383 citations·filing 2010–2024
97Inventor score
Top patents by PatentIndex Score
39 records- 0199US8809320B2Benzodiazepine derivativesLI WEI·Filed 2013·Granted Aug 19, 2014·56 cites·22 claims
- 0299US8802667B2Benzodiazepine derivativesLI WEI·Filed 2013·Granted Aug 12, 2014·55 cites·20 claims
- 0398US9434748B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2015·Granted Sep 6, 2016·15 cites·25 claims
- 0498US8889669B2Cytotoxic benzodiazepine derivativesLI WEI·Filed 2013·Granted Nov 18, 2014·32 cites·40 claims
- 0598US8765740B2Cytotoxic benzodiazepine derivativesLI WEI·Filed 2012·Granted Jul 1, 2014·59 cites·56 claims
- 0697US9169272B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2014·Granted Oct 27, 2015·19 cites·16 claims
- 0797US8426402B2Benzodiazepine derivativesLI WEI·Filed 2010·Granted Apr 23, 2013·69 cites·23 claims
- 0896US10208127B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Feb 19, 2019·6 cites·6 claims
- 0996US10179818B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Granted Jan 15, 2019·6 cites·24 claims
- 1096US9868791B2Methods of preparation of conjugatesIMMUNOGEN INC·Filed 2016·Granted Jan 16, 2018·8 cites·12 claims
- 1196US9840564B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Dec 12, 2017·7 cites·3 claims
- 1295US9353127B2Methods of preparation of conjugatesFISHKIN NATHAN·Filed 2012·Granted May 31, 2016·28 cites·69 claims
- 1394US9265841B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2014·Granted Feb 23, 2016·7 cites·12 claims
- 1493US10570212B2Cytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Feb 25, 2020·3 cites·14 claims
- 1593US9550787B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Granted Jan 24, 2017·4 cites·9 claims
- 1691US10947315B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2018·Granted Mar 16, 2021·2 cites·8 claims
- 1786US2025135017A1Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 1885US10364294B2Methods of preparation of conjugatesIMMUNOGEN INC·Filed 2017·Granted Jul 30, 2019·2 cites·3 claims
- 1984US12043670B2Anti-BCMA antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2021·Granted Jul 23, 2024·1 cites·48 claims
- 2084US11352348B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Jun 7, 2022·1 cites·25 claims
- 2181USRE49918ECytotoxic benzodiazepine derivativesIMMUNOGEN INC·Filed 2021·Granted Apr 16, 2024·0 cites·14 claims
- 2279US11505617B2Benzodiazepine derivativesIMMUNOGEN INC·Filed 2021·Granted Nov 22, 2022·0 cites·4 claims
- 2377US11945807B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Granted Apr 2, 2024·0 cites·24 claims
- 2477US9156854B2Maytansinoid derivatives with sulfoxide linkerFISHKIN NATHAN·Filed 2012·Granted Oct 13, 2015·2 cites·35 claims
- 2576US2024190956A1Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2023·Application pending·0 cites
- 2675US10988531B2Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2015·Granted Apr 27, 2021·1 cites·11 claims
- 2772US2024327535A1Anti-bcma antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2024·Application pending·0 cites
- 2872US2018079823A1Novel benzodiazepine derivativesIMMUNOGEN INC·Filed 2017·Application pending·0 cites
- 2970US12172986B2Splicing modulator antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Granted Dec 24, 2024·0 cites·46 claims
- 3070US11732038B2Conjugates comprising cell-binding agents and cytotoxic agentsIMMUNOGEN INC·Filed 2021·Granted Aug 22, 2023·0 cites·6 claims
- 3165US2017183419A1Novel benzodiazepine derivativesIMMUNOGEN INC·Filed 2016·Application pending·0 cites
- 3262US2023211008A1ConjugatesORUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3359US2025304563A1Activators of effector t cellsORUM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3456US2025144230A1Linkers for use in antibody drug conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3554US9624240B2Maytansinoid derivatives with sulfoxide linkerIMMUNOGEN INC·Filed 2015·Granted Apr 18, 2017·0 cites·18 claims
- 3654US2024252671A1Neodegrader-anti-cd33 antibody conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3754US2023338564A1Neodegrader conjugatesORUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3853US2025090681A1Neodegrader conjugatesORUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3948US2017002393A1Compositions and methods for antibody productionIMMUNOGEN INC·Filed 2014·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →